Skip to main content
. 2018 Mar 19;29(1):27–37. doi: 10.31138/mjr.29.1.27

Figure 4.

Figure 4.

Combination csDMARD therapy patterns.

The different combinations of conventional synthetic disease modifying anti-rheumatic drugs (csDMARDs, n=266, see also figure 2) used in the RA cohort is shown in %.

HCQ, hydroxychloroquine; MTX, methotrexate, LEF, leflunomide; CsA, cyclosporine; SSZ, sulfasalazine.